
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1627503-67-6 | 货号 | BCP12392 |
中文名 | LDN-214117 | ||
英文名 | LDN-214117 | ||
中文别名 | |||
英文别名 | LDN214117;LDN 214117; | ||
SMILES | |||
化学名称 | |||
分子式 | C25H29N3O3 | 分子量 | 419.52 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | LDN-214117 inhibited ALK2 most, with a biochemical IC50 of 24 nM, followed by TNIK, RIPK2, and ABL1. LDN-214117 has a cell-based IC50 for BMP6 of approximately 100 nM and 164-fold selectivity for BMP6 versus TGF-β1. Fibrodysplasia ossificans progressiva (FOP) is a debilitating and progressive heterotopic ossification disease caused by activating mutations of ACVR1 encoding the BMP type I receptor kinase ALK2. LDN-214117 had nearly identical binding affinity for wild-type ALK2 and each of the FOP-causing mutants tested. |
相关产品推荐
查看更多 >Tags:LDN-214117 供应商,LDN-214117 购买,LDN-214117 生产,LDN-214117 批量,LDN-214117 供应,LDN-214117 订购,LDN-214117 采购